Results 91 to 100 of about 1,838,932 (310)

Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma

open access: yesJournal of Immunology Research, 2022
Osteosarcoma is a kind of primary malignant tumor of bone. In recent years, its therapeutic effect and prognostic survival are dissatisfactory. The tumor immune microenvironment (TIME) reflects immune status of patients, but it is little known in ...
Shunhan Yao   +4 more
doaj   +1 more source

Tumor-Infiltrating Immune Cells in Colorectal Cancer [PDF]

open access: yesNeoplasia
Colorectal cancer encompasses a heterogeneous group of malignancies that differ in pathophysiological mechanisms, immune response and infiltration, therapeutic response, and clinical prognosis. Numerous studies have highlighted the clinical relevance of tumor-infiltrating immune cells among different types of colorectal tumors yet vary in cell type ...
Sonia A.M. Ferkel   +4 more
openaire   +4 more sources

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Exploring LTB-mediated T cell differentiation as a prognostic marker in triple-negative breast cancer

open access: yesBreast Cancer Research
Immune infiltration in triple-negative breast cancer (TNBC) is associated with patient prognosis. However, the precise phenotypic classifications of immune infiltration in TNBC remain unclear, and the key regulatory mechanisms underlying this process ...
Xuekai Wang   +7 more
doaj   +1 more source

The correlations of AQPs expression with immune infiltration level in ccRCC.

open access: yes, 2022
The correlations of AQPs expression with immune infiltration level in ccRCC.
Tie Chong (655561)   +8 more
core   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Leveraging machine learning models to evaluate immune infiltration in the ovarian cancer microenvironment: a single-cell analysis approach

open access: yesDiscover Oncology
Background The prognosis of ovarian cancer is closely related to the degree of immune cell infiltration within the tumor microenvironment. However, current methods for assessing immune infiltration have certain subjective limitations. This study aimed to
Jie Liu   +3 more
doaj   +1 more source

CCR2+ migratory macrophages with M1 status are the early-responders in the cornea of HSV-1 infected mice.

open access: yesPLoS ONE, 2019
Complex interactions between HSV-1 and infiltrating immune cells play important roles in establishing localized, acute virus replication as well as chronic latent infection. The extent and duration of initial virus replication are the key determinants of
Dhong Hyun Lee   +2 more
doaj   +1 more source

Correlation between LINC00324 expression and immune infiltration.

open access: yes
Correlation between LINC00324 expression and immune infiltration.
Zhengquan Yu (606806)   +8 more
core   +1 more source

Correlation analysis between PLAUR expression and the relative content of immune cell infiltration.

open access: yes, 2022
Correlation analysis between PLAUR expression and the relative content of immune cell infiltration.
Zengshu Xing (12837293)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy